HAVN Life Sciences Inc.
HAVN
Clasificación en acciones
#38600
HAVN Life Sciences Inc. is a biotechnology firm dedicated to the research and... HAVN Life Sciences Inc. is a biotechnology firm dedicated to the research and creation of psychotropic compounds sourced from flora and fungi. The company's expertise includes devising standardized and quality-assured extraction techniques for psychoactive substances, particularly from Psilocybe mushrooms, to isolate key compounds such as psilocybin, psilocin, and baeocystin. Furthermore, it develops natural health remedies using non-regulated ingredients. This Canadian company, founded in 2020, is headquartered in Richmond.
Precio por acción
$0.02201811
Última sincronización: 2024-07-23
Capitalización bursátil
$847.02K
Cambio (1 día)
-0.22%
Cambio (1 año)
21,918.11%
País
CA
Comercio HAVN Life Sciences Inc. (HAVN)
Categoría
Healthcare
Ratio P/S de HAVN Life Sciences Inc. (HAVN)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de HAVN Life Sciences Inc., el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de HAVN Life Sciences Inc. desde 2026 hasta 2026
Ratio P/S al final de cada año
| Año | Ratio P/S | Cambiar |
|---|---|---|
| Not enough data for the provided dates. | ||
Ratio P/S de empresas similares o competidoras
| Empresa | Ratio P/S | Diferencia del ratio P/S | País |
|---|---|---|---|
| 10.02 | - |
US
|
|
| 40.55 | - |
US
|
|
| 3.96 | - |
AU
|
|
| - | - |
CH
|
|
| 10.15 | - |
NL
|
